Nuvectis Pharma (NVCT)
(Delayed Data from NSDQ)
$6.00 USD
-0.17 (-2.76%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $5.98 -0.02 (-0.33%) 7:58 PM ET
4-Sell of 5 4
D Value C Growth C Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/04/2025
Time: -- |
9/2025 | $-0.25 | 12.00% |
Earnings Summary
For their last quarter, Nuvectis Pharma (NVCT) reported earnings of -$0.30 per share, missing the Zacks Consensus Estimate of -$0.25 per share. This reflects a negative earnings surprise of 20.00%. Look out for NVCT's next earnings release expected on November 04, 2025. For the next earning release, we expect the company to report earnings of -$0.25 per share, reflecting a year-over-year decrease of 4.17%.
Earnings History
Price & Consensus
Zacks News for NVCT
Nuvectis Pharma (NVCT) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
NVCT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Nuvectis Pharma (NVCT) Is a Great Choice for 'Trend' Investors, Here's Why
Wall Street Analysts Predict a 169.94% Upside in Nuvectis Pharma (NVCT): Here's What You Should Know
NVCT FAQs
Based on past history, Zacks believes Nuvectis Pharma, Inc. (NVCT) will report their next quarter earnings on November 04, 2025. For the next earning release, we expect the company to report earnings of -0.25 per share, reflecting a year-over-year increase of -4.17.
Based on past history, Zacks believes Nuvectis Pharma, Inc. (NVCT) will report their previous quarter earnings %%TIME_OF_DAY_CODE%% on November 04, 2025.
The Zacks Consensus Estimate for Nuvectis Pharma, Inc. (NVCT) for the quarter ending in September 2025 is $-0.25 a share. We expect Nuvectis Pharma, Inc. to miss by 12.00%.
In the earnings report for the quarter ending in June 2024, Nuvectis Pharma, Inc. (NVCT) announced earnings of $-0.26 per share versus the Zacks Consensus Estimate of $-0.26 per share, representing a surprise of 0.00%.